Gastrointentinal intolerance metformin and acute diverticulitis
DOI:
https://doi.org/10.32818/reccmi.a5n3a9Keywords:
metformin, adverse effects, diarrhea, colonic diverticulitis.Abstract
Metformin intolerance occurs in 20 to 30% of diabetics; it is definitively suspended in 5% due to severe gastrointestinal effects. We present the case of a 65 year-old male, diabetic type 2, with diverticular disease, who repeatedly presented diarrhea and abdominal pain due to metformin. He was admitted to the intensive care unit for acute diverticulitis and discharged with insulin and definitive withdrawal of metformin. We suggest considering the probability of increased risk for metformin intolerance in the presence of intestinal morphological changes.
Downloads
Metrics
References
Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab. 2011; 37(2): 90-6. doi: https://doi.org/10.1016/j.diabet.2010.11.002.
Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes Obes Metab. 2017; 19(4): 473-81. doi: https://doi.org/10.1111/dom.12854.
Dujic T, Zhou K, Donnelly LA, Tavendale R, Palmer CNA, Pearson ER. Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. Diabetes. 2015; 64(5): 1786-93. doi: https://doi.org/10.2337/db14-1388.
Elbere I, Kalnina I, Silamikelis I, Konrade I, Zaharenko L, Sekace K et al. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLoS One. 2018; 13(9): e0204317. doi: https://doi.org/10.1371/journal.pone.0204317.
McCreight LJ, Stage TB, Connelly P, Lonergan M, Nielsen F, Prehn C, et al. Pharmacokinetics of metformin in patients with gastrointestinal intolerance. Diabetes Obes Metab. 2018; 20(7): 1593-601. doi: https://doi.org/10.1111/dom.13264.
McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetología. 2016; 59: 426-35. doi: https://doi.org/10.1007/s00125-015-3844-9.
Zhou K, Donnelly LA, Kimber CH, Donnan P, Doney A, Leese G, et al. Re- duced-function SLC22A1 polymorphisms encoding organic cation trans- porter 1 and glycemic response to metformin: a GoDARTS study. Diabetes. 2009; 58: 1434–1439. doi: https://doi.org/10.2337/db08-0896.
Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, et al. Met- formin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017; 23(7): 850-8. doi: https://doi.org/10.1038/nm.4345.
Fluxá D, Quera R. Enfermedad diverticular: mitos y realidades [Diverticu- lar disease: myths and realities]. Rev Med Chil. 2017; 145(2): 201-208. doi: https://doi.org/10.4067/S0034-98872017000200009.
Freckelton J, Evans JA, Croagh D, Moore GT. Metformin use in diabetics with diverticular disease is associated with reduced incidence of diverticulitis. Scand J Gastroenterol. 2017; 52(9): 969-72. doi: https://doi.org/10.1080/00365521.2017.1325930.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Carlos Walter Contreras-Camarena, Humberto Lira-Veliz
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
